|
|
|
| |||||||||||||||||||||||||||||||||||||||
4 November 2008 | Volume 149 Issue 9
Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for colorectal cancer.
Methods: In order to update its recommendation, the USPSTF commissioned 2 studies: 1) a targeted systematic evidence review on 4 selected questions relating to test characteristics and benefits and harms of screening technologies; and 2) a decision analytic modeling analysis using population modeling techniques to compare the expected health outcomes and resource requirements of available screening modalities when used in a programmatic way over time.
Recommendations: The USPSTF recommends screening for colorectal cancer using fecal occult blood testing, sigmoidoscopy, or colonoscopy in adults, beginning at age 50 years and continuing until age 75 years. The risks and benefits of these screening methods vary. (A recommendation.)
The USPSTF recommends against routine screening for colorectal cancer in adults 76 to 85 years of age. There may be considerations that support colorectal cancer screening in an individual patient. (C recommendation.)
The USPSTF recommends against screening for colorectal cancer in adults older than age 85 years. (D recommendation.)
The USPSTF concludes that the evidence is insufficient to assess the benefits and harms of computed tomographic colonography and fecal DNA testing as screening modalities for colorectal cancer. (I statement.)
Author and Article Information
From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Reprints are available from the Agency for Healthcare Research and Quality Web site (www.preventiveservices.ahrq.gov). CLINICAL GUIDELINES
Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
This article has been cited by other articles:
![]() |
R. H Fletcher Colorectal cancer screening: for prevention or cure? J Epidemiol Community Health, July 1, 2009; 63(7): 505 - 506. [Full Text] [PDF] |
||||
![]() |
J. L. Warren, C. N. Klabunde, A. B. Mariotto, A. Meekins, M. Topor, M. L. Brown, and D. F. Ransohoff Adverse Events After Outpatient Colonoscopy in the Medicare Population Ann Intern Med, June 16, 2009; 150(12): 849 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Roy, V. Turzhitsky, Y. Kim, M. J. Goldberg, P. Watson, J. D. Rogers, A. J. Gomes, A. Kromine, R. E. Brand, M. Jameel, et al. Association between Rectal Optical Signatures and Colonic Neoplasia: Potential Applications for Screening Cancer Res., May 15, 2009; 69(10): 4476 - 4483. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Walter, K. Lindquist, S. Nugent, T. Schult, S. J. Lee, M. A. Casadei, and M. R. Partin Impact of Age and Comorbidity on Colorectal Cancer Screening Among Older Veterans Ann Intern Med, April 7, 2009; 150(7): 465 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Petitti, S. M. Teutsch, M. B. Barton, G. F. Sawaya, J. K. Ockene, T. DeWitt, and on behalf of the U.S. Preventive Services Task For Update on the Methods of the U.S. Preventive Services Task Force: Insufficient Evidence Ann Intern Med, February 3, 2009; 150(3): 199 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith, V. Cokkinides, and O. W. Brawley Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening CA Cancer J Clin, January 1, 2009; 59(1): 27 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pignone and H. C. Sox Screening Guidelines for Colorectal Cancer: A Twice-Told Tale Ann Intern Med, November 4, 2008; 149(9): 680 - 682. [Full Text] [PDF] |
||||
Read all Rapid Responses